The 2026 definition of ruxolitinib refractoriness in severe acute GVHD
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Malard F.
- Chen Y.B.
- Al Malki M.M.
- Perales M.-A.
- Peric Z.
- Ruggeri A.
- Brissot E.
- Duarte R.
- Morsink L.
- Spyridonnidis A.
- Battipaglia G.
- Nakamura R.
- Kharfan-Dabaja M.
- Penak O.
- Zeiser R.
- Mohty M.
Grupos
Abstract
[No abstract available]
Datos de la publicación
- ISSN/ISSNe:
- 0268-3369, 1476-5365
- Tipo:
- Letter
- Páginas:
- 972-974
- PubMed:
- 42191985
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 0,998 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
BONE MARROW TRANSPLANTATION SPRINGERNATURE
Documentos
- No hay documentos
Filiaciones
Keywords
- bilirubin; narcotic analgesic agent; ruxolitinib; transthyretin; ruxolitinib; abdominal pain; acute graft versus host disease; body weight loss; bullous skin disease; desquamation; drug toxicity and intoxication; drug withdrawal; dysbiosis; ECOG Performance Status; endothelium injury; erythrocyte concentrate; feces analysis; gastrointestinal acute graft versus host disease; gastrointestinal acute graft versus host disease; graft versus host reaction; hematochezia; human; hypoalbuminemia; Letter; malnutrition; nutritional status; sepsis; therapy resistance; toxicity; acute graft versus host disease; diagnosis; letter; therapy
Portal de investigación